There is a potential for life-threatening medication errors with two heparin preparations News item 19 January 2013 Pages: 2 - 2
The US FDA has issued a Public Health Advisory about life threatening adverse effects associated with topical anaesthetics for cosmetic procedures Media release 19 January 2013 Pages: 3 - 3
Bayer HealthCare has announced that it is to end three ongoing clinical studies Media release 19 January 2013 Pages: 3 - 3
According to WHO and UNAIDS (The Joint United Nations Programme on HIV/AIDS), a phase III study* of the microbicide cellulose sulfate Media release 19 January 2013 Pages: 3 - 3
The US FDA has finalised revisions to the Ketek [telithromycin] label, which include removing two of the three previously approved indications Media release 19 January 2013 Pages: 3 - 3
Etoricoxib: upper GI events less common than with diclofenac Clinical study 19 January 2013 Pages: 4 - 4
Cutting the use of benzodiazepines among the elderly by over 50% did not lead to a corresponding decrease in hip fractures Incidence study 19 January 2013 Pages: 4 - 4
Dehydroepiandrosterone sulfate (DHEAS) levels were below normal in the majority of outpatients receiving daily systemic opioid therapy Clinical study 19 January 2013 Pages: 4 - 4
